[go: up one dir, main page]

ZA200402859B - Differentially expressed genes associated with obesity and type 2 diabetes. - Google Patents

Differentially expressed genes associated with obesity and type 2 diabetes.

Info

Publication number
ZA200402859B
ZA200402859B ZA200402859A ZA200402859A ZA200402859B ZA 200402859 B ZA200402859 B ZA 200402859B ZA 200402859 A ZA200402859 A ZA 200402859A ZA 200402859 A ZA200402859 A ZA 200402859A ZA 200402859 B ZA200402859 B ZA 200402859B
Authority
ZA
South Africa
Prior art keywords
obesity
diabetes
type
differentially expressed
expressed genes
Prior art date
Application number
ZA200402859A
Other languages
English (en)
Inventor
Greg Collier
Ken Walder
Andrea Michelle De Silva
Paul Zev Zimmet
Janine Mcmillan
Kelly Windmill
Original Assignee
Autogen Res Pty Ltd
Internat Diabetes Inst And Dea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autogen Res Pty Ltd, Internat Diabetes Inst And Dea filed Critical Autogen Res Pty Ltd
Publication of ZA200402859B publication Critical patent/ZA200402859B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
ZA200402859A 2001-10-16 2004-04-15 Differentially expressed genes associated with obesity and type 2 diabetes. ZA200402859B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33014901P 2001-10-16 2001-10-16

Publications (1)

Publication Number Publication Date
ZA200402859B true ZA200402859B (en) 2005-01-24

Family

ID=23288511

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200402859A ZA200402859B (en) 2001-10-16 2004-04-15 Differentially expressed genes associated with obesity and type 2 diabetes.

Country Status (9)

Country Link
EP (1) EP1446414A4 (xx)
JP (1) JP2005510214A (xx)
KR (1) KR20040088019A (xx)
CN (1) CN1596264A (xx)
CA (1) CA2463578A1 (xx)
IL (1) IL161294A0 (xx)
MX (1) MXPA04003635A (xx)
WO (1) WO2003033513A1 (xx)
ZA (1) ZA200402859B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513300A1 (en) * 2003-01-13 2004-07-29 Autogen Research Pty Ltd Obesity-related genes
DE10352510A1 (de) * 2003-11-07 2005-06-23 Forschungsinstitut Für Die Biologie Landwirtschaftlicher Nutztiere Verfahren zur Identifizierung von Wirkstoffen zur Beeinflussung der Körpermasse und des Fettansatzes
EP1709174B1 (en) * 2003-12-24 2012-02-08 Samsung Electronics Co., Ltd Use of a polynucleotide associated with a type ii diabetes mellitus comprising single nucleotide polymorphism, use of a microarray and diagnostic kit comprising the same and method for analyzing polynucleotide using the same
WO2005090378A1 (en) * 2004-03-16 2005-09-29 Agt Biosciences Limited Ligands of the molecule fit (agt-121) and their pharmaceutical use
CA2587790A1 (en) * 2004-12-07 2006-06-15 Ohio University Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum
CN115851931A (zh) * 2021-06-28 2023-03-28 广东医科大学附属第二医院 一种肝癌分子标志物在制备肝癌检测或疗效评价产品中的应用
CN114958875B (zh) * 2022-05-15 2023-08-18 赣南师范大学 柑橘黄龙病菌内参基因metG筛选和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780405B1 (fr) * 1998-06-25 2001-12-28 Centre Nat Rech Scient Nouveaux recepteurs olfactifs et leurs utilisations
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
EP1446414A1 (en) 2004-08-18
JP2005510214A (ja) 2005-04-21
CN1596264A (zh) 2005-03-16
KR20040088019A (ko) 2004-10-15
EP1446414A4 (en) 2005-11-23
IL161294A0 (en) 2004-09-27
WO2003033513A1 (en) 2003-04-24
MXPA04003635A (es) 2004-07-30
CA2463578A1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
MXPA02012749A (es) Moleculas semejantes a b7 y sus usos.
MXPA02009324A (es) Montaje para llevar al frente y exhibidor de productos.
MXPA03005787A (es) Hidrogeles revestidos con separadores estericos o electrostaticos.
AU4020501A (en) Enhancing touch and feel on the internet
AU2002247269A1 (en) Genes and polymorphisms associated with cardiovascular disease and their use
EG23266A (en) Shrink resistant and wrinkle free textilles.
ZA200402859B (en) Differentially expressed genes associated with obesity and type 2 diabetes.
EP1164192A4 (en) SORBITOL-DEHYDROGENASE, CODING GENE AND THE USE THEREOF
MXPA03000514A (es) Lectinas relacionadas a inmunoglobulina con enlace a acido sialico y usos de los mismos.
AU2003285069A8 (en) Type 2 diabetes mellitus genes
MXPA03007270A (es) Moleculas de receptores acoplados a proteina g y usos de las mismas.
AU1509501A (en) A novel polypeptide, a human deafness-related gene 14 and the polynucleotide encoding the polypeptide
AP2006003504A0 (en) Outer surface proteins, their genes, and their use.
MXPA03007596A (es) Lacas de poliuretano de 1c de secado al horno y su uso.
AU8229901A (en) Genes and proteins, and their uses
TerMeer Tectonometamorphic history of the Nowyak complex, Nunavut/Maria M. Termeer.
AU2001231484A1 (en) A novel polypeptide, secp43, 32 that associates specifically with human selecnocysteine trna and the polynucleotide encoding thereof
AU2002364894A8 (en) Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
EP1189920A4 (en) FAMILY OF GENES CAMELLO AND THE USE OF THE SAID GENES
AU2002319017A1 (en) Obesity related genes expressed at least in the hypothalamus
Faulkner Santamarian 2001
Pierce EARLY COLONICAL CAPITAL FORMATION
ZA992031B (en) Plasminogen-related gene B polypeptides.
Packendorff Att främja näringslivsutveckling: En framtidsinriktad utvärdering av affärsrådgivning för kvinnor
MXPA02012718A (es) Moleculas semejantes a b7 y sus usos.